Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 2/28/2026Recent Executive Moves
  • 2/28/2026China-SCO Cooperation Center for Metabolic Diseases Launched in Shangh...
  • 2/28/2026China's Tech Giants Pour Billions Into AI Healthcare Amid Uncertain Bu...
  • 2/28/2026bioMérieux CEO Flags "Negative Healthcare Market Evolution" in China
  • 2/27/2026CSPC Launches Phase III Program for SYH2053 PCSK9 siRNA in China
  • 2/27/2026Duality Reports Updated DB-1311/BNT324 Data at ASCO GU 2026
  • 2/27/2026Evopoint Biosciences Highlights Igermetostat Data at ASCO GU 2026 in m...
  • 2/26/2026BMS-Partnered Bispecific ADC Achieves Dual Survival Milestones in Chin...
  • 2/26/2026China's Biopharma Boom Attracts Global Investment Amid Innovation Surg...
  • 2/26/2026China Expands Mutual Recognition of Medical Tests to Streamline Care a...
  • 2/26/2026U.S. ITC to Probe China's Trade Status and Biotech Practices
  • 2/26/2026Health Guard's Trial Suspensions Deepen Pressure on China's HPV Vaccin...
  • 2/26/2026China Pharmaceutical Market Projected to Reach US$573B by 2033
  • 2/26/2026Jiuyuan Files for Approval of Wegovy Biosimilar in China
  • 2/26/2026Pfizer Updates Pneumococcal Vaccine Trial in China, Implications for I...
  • 2/26/2026China Accelerates Dementia Research to Challenge U.S. Leadership
  • 2/25/2026China Schedules Antitrust Hearing in Abuse‑of‑Dominance Case Tied to...
  • 2/25/2026CStone Secures UK Approval for Sugemalimab in Stage III NSCLC
  • 2/25/2026CASI Pharma to Be Delisted from Nasdaq, Shares to Move to OTC Market
  • 2/25/2026CDE Solicits Comments on Batch 104 of Chemical Generic Reference Formu...
  • 2/25/2026Kelun-Biotech's sac-TMT OS Data Selected as Late-Breaker at ELCC 2026
  • 2/25/2026Prodegre Closes Angel+ Round to Advance CNS Pipeline and ATLAS™ Platf...
  • 2/25/2026Slate Medicines Launches With $130M to Advance China-Licensed PACAP Mi...
  • 2/25/2026Henlius Expands Global Footprint with Exclusive Abbott Licensing Deal ...
  • 2/24/2026Biokin's Iza-Bren Achieves Second Phase III Survival Success in China ...
  • 2/24/2026China Prepares to Implement Landmark Regulations for Clinical Research...
  • 2/24/2026CDE Issues Guidelines on Benefit-Risk Assessment Using Multi-Regional ...
  • 2/24/2026CDE Releases Q&A Document on Development Safety Update Reports
  • 2/24/2026CDE Issues Guideline on Clinical Information for CAR-T Therapy Package...
  • 2/24/2026Huadong Launches Head-to-Head Phase III Trial for Dual GLP-1/GIP Agoni...
  • Page:1/60 Total number of articles:1799: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group